Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection

Transplantation

Volumn 78, Issue 1, 2004, Pages 65-70

  Krukemeyer, Manfred G ^a   Moeller, Johannes ^a   Morawietz, Lars ^a   Rudolph, Birgit ^a   Neumann, Ulf ^a   Theruvath, Tom ^a   Neuhaus, Peter ^a   Krenn, Veit ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

B lymphocytes; Chemokines; Liver transplant rejection; Plasma cells

Indexed keywords

CD20 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 1; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE LIVER ALLOGRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LYMPHOCYTE MIGRATION; MALE; PLASMA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIGENS, CD20; B-LYMPHOCYTES; BIOPSY; CHEMOKINE CCL20; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL12; CHEMOKINE CXCL9; CHEMOKINES, CC; CHEMOKINES, CXC; CHILD; CHILD, PRESCHOOL; COMPLEMENT C4; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; INFANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; LIVER TRANSPLANTATION; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMA CELLS; PROTEOGLYCANS; RECEPTORS, CCR6; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; RECEPTORS, CXCR4; SYNDECAN-1; SYNDECANS; TRANSPLANTATION, HOMOLOGOUS;

EID: 3142765991     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000132324.14207.8B     Document Type: Article

References (26)

1. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31: 792-799.
2. Goddard S, Williams A, Morland C, et al. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001; 72: 1957-1967.
3. Briscoe DM, Alexander SI, Lichtman AH. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol 1998; 10: 525-531.
4. McCaughan GW, Davies JS, Waugh JA, et al. A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology 1990; 12: 1305-1313.
5. Takakura K, Kiuchi T, Kasahara M, et al. Humoral immunity in acute cellular rejection after living-donor liver transplantation. Transplant Proc 1999; 31: 526-527.
6. Vella JP, Magee C, Vos L, et al. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 1999; 67: 1523-1532.
7. Dollinger MM, Howie SE, Plevris JN, et al. Intrahepatic proliferation of "naïve" and "memory" T cells during liver allograft rejection: primary immune response within the allograft. FASEB J 1998; 12: 939-947.
8. Hauser AE, Debes GF, Arce S, et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 2002; 169: 1277-1282.
9. Liao F, Shirakawa AK, Foley JF, et al. Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 2002; 168: 4871-4880.
10. Welsh K, Bunce M. Molecular typing for the MHC with PCR-SSP. Rev Immunogenet 1999; 1(2): 157.
11. Amos DB, Bashir H, Boyle W, et al. A simple microcytotoxicity test. Transplantation 1969; 7: 220-223.
12. Pirofsky B, Rosner ER. DTT test: a new method to differentiate IgM and IgG erythrocyte antibodies. Vox Sang 1974; 27: 480-488.
13. Arce E, Jackson DG, Gill MA, et al. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001; 167: 2361-2369.
14. Medina F, Segundo C, Campos-Caro A, et al. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002; 99: 2154-2161.
15. Magalhaes R, Stiehl P, Morawietz L, et al. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002; 441: 415-427.
16. Sun J, McCaughan GW, Matsumoto Y, et al. Tolerance to rat liver allografts. 1. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994; 57: 1349-1357.
17. Forster R, Mattis AE, Kremmer E, et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996; 87: 1037-1047.
18. Hargreaves DC, Hyman PL, Lu TT, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001; 194: 45-56.
19. Sullivan SK, McGrath DA, Liao F, et al. MIP-3alpha induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK). J Leukoc Biol 1999; 66: 674-682.
20. Greaves DR, Wang W, Dairaghi DJ, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 1997; 186: 837-844.
21. Scapini P, Laudanna C, Pinardi C, et al. Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19. Eur J Immunol 2001; 31: 1981-1988.
22. Chabaud M, Page G, Miossec P. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 2001; 167: 6015-6020.
23. Nakayama T, Hieshima K, Izawa D, et al. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003; 170: 1136-1140.
24. Neumann UP, Guckelberger O, Langrehr JM, et al. Impact of human leukocyte antigen matching in liver transplantation. Transplantation. 75(1):132-7, 2003.
25. Dubel L, Farges O, Johanet C, et al. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998; 65: 1072-1075.
26. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 2003; 18: 2232-2239.